143 related articles for article (PubMed ID: 36930831)
1. UBE2C-mediated Autophagy Inhibition via Ubiquitination of SIRT1 Contributes to Endometrial Cancer Progression.
Zhao R; Liu Y; Wang Z; Zhang J; Zhang W; Zhou X; Tsedendorj S; Enkhtur A; Feng D; Wang H
Mol Cancer Res; 2023 Jun; 21(6):564-577. PubMed ID: 36930831
[TBL] [Abstract][Full Text] [Related]
2.
Liu Y; Zhao R; Chi S; Zhang W; Xiao C; Zhou X; Zhao Y; Wang H
Mol Cancer Res; 2020 Feb; 18(2):204-215. PubMed ID: 31662448
[TBL] [Abstract][Full Text] [Related]
3. Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.
Guo L; Ding Z; Huang N; Huang Z; Zhang N; Xia Z
Cell Cycle; 2017 Sep; 16(18):1705-1718. PubMed ID: 28767320
[TBL] [Abstract][Full Text] [Related]
4. Ube2v1-mediated ubiquitination and degradation of Sirt1 promotes metastasis of colorectal cancer by epigenetically suppressing autophagy.
Shen T; Cai LD; Liu YH; Li S; Gan WJ; Li XM; Wang JR; Guo PD; Zhou Q; Lu XX; Sun LN; Li JM
J Hematol Oncol; 2018 Jul; 11(1):95. PubMed ID: 30016968
[TBL] [Abstract][Full Text] [Related]
5. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
6. Sirtuin 1 promotes autophagy and proliferation of endometrial cancer cells by reducing acetylation level of LC3.
Huang S; Li Y; Sheng G; Meng Q; Hu Q; Gao X; Shang Z; Lv Q
Cell Biol Int; 2021 May; 45(5):1050-1059. PubMed ID: 33438275
[TBL] [Abstract][Full Text] [Related]
7. Ceramide synthase 6 antisense RNA 1 contributes to the progression of breast cancer by sponging miR-16-5p to upregulate ubiquitin-conjugating enzyme E2C.
Pan W; Chen KJ; Huang YC
Anticancer Drugs; 2022 Oct; 33(9):913-922. PubMed ID: 36136991
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitin-conjugating enzyme E2C regulates apoptosis-dependent tumor progression of non-small cell lung cancer via ERK pathway.
Zhang Z; Liu P; Wang J; Gong T; Zhang F; Ma J; Han N
Med Oncol; 2015 May; 32(5):149. PubMed ID: 25832867
[TBL] [Abstract][Full Text] [Related]
9. The UBE2C/CDH1/DEPTOR axis is an oncogene and tumor suppressor cascade in lung cancer cells.
Zhang S; You X; Zheng Y; Shen Y; Xiong X; Sun Y
J Clin Invest; 2023 Feb; 133(4):. PubMed ID: 36548081
[TBL] [Abstract][Full Text] [Related]
10. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
11. Overexpressed lncRNA FTX promotes the cell viability, proliferation, migration and invasion of renal cell carcinoma via FTX/miR‑4429/UBE2C axis.
Chen Z; Zhang M; Lu Y; Ding T; Liu Z; Liu Y; Zhou Z; Wang L
Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35866591
[TBL] [Abstract][Full Text] [Related]
12. LncRNA FIRRE regulated endometrial cancer radiotherapy sensitivity via the miR-199b-5p/SIRT1/BECN1 axis-mediated autophagy.
Cai J; Wang R; Chen Y; Zhang C; Fu L; Fan C
Genomics; 2024 Jan; 116(1):110750. PubMed ID: 38052260
[TBL] [Abstract][Full Text] [Related]
13. Anticancer effect of icaritin on prostate cancer via regulating miR-381-3p and its target gene UBE2C.
Hu J; Wu X; Yang C; Rashid K; Ma C; Hu M; Ding Q; Jiang H
Cancer Med; 2019 Dec; 8(18):7833-7845. PubMed ID: 31646760
[TBL] [Abstract][Full Text] [Related]
14. Ligand-based discovery of small molecules suppressing cancer cell proliferation via autophagic flux inhibition.
Liu L; Tian Z; Zhang Y; Liu P; Xin Z; Zhao Y; Li Y; Miao S; Shi J; Chen Z; Liu J; Zhang H
J Mol Med (Berl); 2020 Nov; 98(11):1573-1589. PubMed ID: 32897390
[TBL] [Abstract][Full Text] [Related]
15. Depletion of UBE2C reduces ovarian cancer malignancy and reverses cisplatin resistance via downregulating CDK1.
Li J; Zhi X; Shen X; Chen C; Yuan L; Dong X; Zhu C; Yao L; Chen M
Biochem Biophys Res Commun; 2020 Mar; 523(2):434-440. PubMed ID: 31875843
[TBL] [Abstract][Full Text] [Related]
16. UBE2C promotes rectal carcinoma via miR-381.
Zhang Y; Tian S; Li X; Ji Y; Wang Z; Liu C
Cancer Biol Ther; 2018 Mar; 19(3):230-238. PubMed ID: 29303411
[TBL] [Abstract][Full Text] [Related]
17. High expression of ubiquitin-conjugating enzyme 2C (UBE2C) correlates with nasopharyngeal carcinoma progression.
Shen Z; Jiang X; Zeng C; Zheng S; Luo B; Zeng Y; Ding R; Jiang H; He Q; Guo J; Jie W
BMC Cancer; 2013 Apr; 13():192. PubMed ID: 23587173
[TBL] [Abstract][Full Text] [Related]
18. UBE2C is overexpressed in ESCC tissues and its abrogation attenuates the malignant phenotype of ESCC cell lines.
Palumbo A; Da Costa NM; De Martino M; Sepe R; Pellecchia S; de Sousa VP; Nicolau Neto P; Kruel CD; Bergman A; Nasciutti LE; Fusco A; Pinto LF
Oncotarget; 2016 Oct; 7(40):65876-65887. PubMed ID: 27588470
[TBL] [Abstract][Full Text] [Related]
19. Ubiquitin-conjugating enzyme E2C: a potential cancer biomarker.
Xie C; Powell C; Yao M; Wu J; Dong Q
Int J Biochem Cell Biol; 2014 Feb; 47():113-7. PubMed ID: 24361302
[TBL] [Abstract][Full Text] [Related]
20. Iron overload inhibits cell proliferation and promotes autophagy via PARP1/SIRT1 signaling in endometriosis and adenomyosis.
Zhou Y; Zhao X; Zhang L; Xia Q; Peng Y; Zhang H; Yan D; Yang Z; Li J
Toxicology; 2022 Jan; 465():153050. PubMed ID: 34826546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
